Merck (MRK) Gains from Equity Investments (2009 - 2026)
Merck's Gains from Equity Investments came in at $42 million for FY2017, down 51.2% from $86 million in FY2016.
Powered by 
Analysis
Merck (MRK) Gains from Equity Investments (2009 - 2026) Analysis & Trends
Going back to FY2009, Merck's Gains from Equity Investments data covers 9 years.
- Gains from Equity Investments has declined in each of the last five years, with a five-year compound annual growth rate of -42.0% (FY2012 to FY2017).
- The FY2017 figure represents the lowest annual Gains from Equity Investments in data going back to FY2009.
- Per Business Quant, earlier years put Gains from Equity Investments at $86 million in FY2016 (-58.0%), $205 million in FY2015 (-20.2%), $257 million in FY2014 (-36.4%) and $404 million in FY2013 (-37.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -400.00 Mn |
| Jun 30, 2026 | -243.00 Mn |
| Mar 31, 2026 | -168.00 Mn |
| Dec 31, 2025 | 195.00 Mn |
| Sep 30, 2025 | -374.00 Mn |
| Jun 30, 2025 | -99.00 Mn |
| Mar 31, 2025 | -90.00 Mn |
| Dec 31, 2024 | 155.00 Mn |
| Sep 30, 2024 | 31.00 Mn |
| Jun 30, 2024 | -57.00 Mn |
| Mar 31, 2024 | -143.00 Mn |
| Dec 31, 2023 | -100.00 Mn |
| Sep 30, 2023 | 34.00 Mn |
| Jun 30, 2023 | 176.00 Mn |
| Mar 31, 2023 | -450.00 Mn |
| Dec 31, 2022 | 58.00 Mn |
| Sep 30, 2022 | 370.00 Mn |
| Jun 30, 2022 | 283.00 Mn |
| Mar 31, 2022 | 708.00 Mn |
| Dec 31, 2021 | -405.00 Mn |
API Access
Merck Gains from Equity Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-equity-investments", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-equity-investments&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();